ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2044

Trying to Improve Care: A Review of the Morbidity and Mortality Conference in the Division of Rheumotology

Michelle Batthish1, Shirley Tse2, Brian M. Feldman3, G. Ross Baker4 and Ronald Laxer5, 1Pediatric Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 2Rheumatology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, 3Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 4Institute of Health Policy, Management and Evaluation, The University of Toronto, Toronto, ON, Canada, 5Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: morbidity and mortality

  • Tweet
  • Email
  • Print
Session Information

Title: Quality Measures and Innovations in Practice Management and Care Delivery

Session Type: Abstract Submissions (ACR)

Background/Purpose:

The morbidity and mortality conference (M&MC) is one of academic medicine’s most visible fora for discussion of adverse events and errors; however it is unclear whether the M&MC is effective in its role to help reduce these events and thereby improve healthcare.  In some contexts, the M&MC has been shown to be an effective forum for addressing patient safety and quality improvement competencies.  However, there is marked variability in the process and standards for the M&MC.  Little is known regarding the extent to which adverse events and errors are actually discussed in the M&MC. To describe the frequency of reported events as well as system improvement recommendations in the M&MC within the Division of Rheumatology at the Hospital for Sick Children (SickKids).

Methods:

A five-year retrospective review of the M&MC minutes within the Division of Rheumatology at SickKids was completed.  Descriptive data including the number of cases, attendance and types and location of reported events were collected.  All events were categorized using an adaptation of the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) index.  Recommendations were classified in the categories used by the Institute for Safe Medication Practices (ISMP) Canada.

Results:

Between January 2007 and December 2011, a total of 30 regularly scheduled M&MCs were held.  The mean attendance was 19 individuals per session.  Eighty-one cases were reviewed (mean 2.7 cases/session) with 2 reported deaths and 4 planned transfers to the intensive care unit.  The most common type of events were related to “miscommunication” (35.8% of cases) followed by events related to a treatment/test/procedure (23.5%).  There were fewer events related to medications such as adverse drug reactions (12.3%), medication administration errors (8.7%).  Most events occurred in the in-patient setting (40%) followed by the Medical Day Care Unit (26%).  Category A events (“an event that has the capacity to cause error”) were the most common (46.9%).  The next most common events were Category C events (“an event occurred that reached the patient but did not cause harm”) followed by Category E events (“an event occurred that may have contributed to or resulted in temporary harm and required intervention”) with 24.7% and 19.8% of the cases, respectively. A total of 89 recommendations were made over the 5 year period. Just over half of these were classified as “information” according to ISMP Canada (58.4%).  This was followed by 11 “rules and policies” recommendations (12.4%) and 8 “reminders, check lists and double check systems” recommendations (9%). There were 36 action items generated from these recommendations; 36% have been completed while 27.8% are ongoing. 

Conclusion:

The M&MC within the Division of Rheumatology reviews a varied number of adverse events.  Increased reporting and study of adverse events and errors can lead to system improvements and safer health care.  Further research is needed to develop innovative models of the M&MC, which focus on patient safety and systems improvement.  This could lead to the creation of a standard review process which has greater potential to improve quality of care.


Disclosure:

M. Batthish,
None;

S. Tse,
None;

B. M. Feldman,

Bayer,

2,

Baxter,

,

Pfizer Inc,

,

Novartis Pharmaceutical Corporation,

;

G. R. Baker,
None;

R. Laxer,

Novartis Pharmaceutical Corporation,

2.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trying-to-improve-care-a-review-of-the-morbidity-and-mortality-conference-in-the-division-of-rheumotology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology